Reduction of Hemolysis in Specimens from Patients in Emergency Departments: Evaluation of Laboratory Medicine Best Practices and Recommendations
The purpose of the project is to evaluate the clinical laboratory best practice recommendations for reducing blood sample hemolysis rates developed through the Laboratory Medicine Best PracticesTM (LMBPTM) Initiative of the Centers for Disease Control and Prevention.
These recommendations were the product of a systematic review for evidence of effectiveness for practices to reduce hemolysis and were developed using the A6 Method established through the LMBPTM Initiative.
The project seeks to measure the extent of improvement that results from implementation of these evidence-based best practice recommendations.
The project can be implemented as a study conducted in multiple institutions or facilities in a healthcare system.
The purpose is limited to quality improvement associated with delivering healthcare, and the associated measuring and reporting of performance data.
These recommendations were the product of a systematic review for evidence of effectiveness for practices to reduce hemolysis and were developed using the A6 Method established through the LMBPTM Initiative.
The project seeks to measure the extent of improvement that results from implementation of these evidence-based best practice recommendations.
The project can be implemented as a study conducted in multiple institutions or facilities in a healthcare system.
The purpose is limited to quality improvement associated with delivering healthcare, and the associated measuring and reporting of performance data.
Related Programs
Laboratory Training, Evaluation, and Quality Assurance Programs
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention
Estimated Funding: $600,000
Office: Centers for Disease Control and Prevention
Estimated Funding: $600,000
Who's Eligible
Obtain Full Opportunity Text:
Additional Information of Eligibility:
Selected applicant eligibility is in compliance with applicant eligibility authorized under statuatory authority Public Health Service Act, Section 317(k)(2), 42 U.S.C 247b(k)(2), and the Catalog of Federal Domestic Assistance (CFDA) number 93.064.
Applicants must have experience in the administration and evaluation of standardized quality assurance programs in multiple, diverse laboratory sites (including community hospitals and academic medical centers) as specified in CFDA 93.064.
Full Opportunity Web Address:
Contact:
Paramjit Sandhuhkx9@cdc.gov
Agency Email Description:
Grants Policy
Agency Email:
hkx9@cdc.gov
Date Posted:
2015-03-13
Application Due Date:
2015-05-12
Archive Date:
2015-06-11
Social Entrepreneurship
Spotlight
When it Comes to Social Enterprises, Failure is the Best Platform for Innovation
In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.
Learn How to Identify and Avoid Grant Scams
